DoD Prostate Cancer, Early Investigator Research Award

The Department of Defense Prostate Cancer Research Program Early Investigator Research Award is a federal research funding opportunity administered by the Department of the Army through the U.S. Army Medical Research Acquisition Activity under Assistance Listing 12.420, Military Medical Research and Development. The opportunity is part of the fiscal year 2026 Prostate Cancer Research Program portfolio and is designed to support innovative prostate cancer research led by investigators who are in the earliest stages of their postdoctoral careers. The funding mechanism specifically emphasizes the development of new scientific talent in prostate cancer research by pairing early-career principal investigators with experienced mentors who possess established expertise in the field. The opportunity was released as a forecasted Grants.gov notice with an estimated posting date of May 20, 2026. The purpose of the award is to advance prostate cancer research while simultaneously fostering the career development of emerging investigators. Applications must address at least one of the fiscal year 2026 Prostate Cancer Research Program Overarching Challenges identified by the funding agency. The award is intended for researchers who possess a doctoral degree or equivalent and who have fewer than three years of postdoctoral research experience as of the application submission deadline. Clinical residency and clinical fellowship training periods are excluded from the calculation of postdoctoral research experience. The funding announcement emphasizes that the early-career investigator must serve as the principal investigator for the proposed project, reinforcing the program's focus on leadership development and independent research capability. A central component of the funding mechanism is structured mentorship. Each application must include at least one mentor with demonstrated experience in prostate cancer research and a record of successful mentorship. In addition to the scientific research proposal, applicants are required to submit a researcher development plan that outlines an individualized strategy for acquiring the skills, competencies, and expertise necessary to complete the proposed project and support long-term career advancement. The development plan is expected to demonstrate how the applicant will gain professional growth opportunities through the mentorship arrangement and research activities funded by the award. The inclusion of mentorship and training requirements distinguishes this program from standard research project grants and positions it as a career development opportunity in addition to a research funding mechanism. The opportunity is categorized under Science and Technology and other Research and Development and is expected to support approximately 14 awards with an estimated total program funding amount of $8,820,000. Specific award ceiling and award floor amounts were not provided in the forecast notice. The funding instrument type is listed as a grant, and the notice explicitly states that no cost sharing or matching requirement applies to applicants. Although the forecast notice does not provide a detailed statement of allowable or unallowable costs, projects are expected to support prostate cancer-related scientific research activities consistent with Department of Defense medical research priorities and the objectives of the Prostate Cancer Research Program. Additional budget guidance and allowable expense details are anticipated to be included in the full funding announcement upon release. Eligibility for the opportunity is listed as unrestricted, subject to clarifications in the official funding announcement. However, the notice specifically defines the target applicant population as early-career investigators meeting the postdoctoral experience requirement. Because the funding opportunity is distributed through Grants.gov and the Department of Defense research infrastructure, eligible applicants may include institutions of higher education, nonprofit organizations, for-profit organizations, and other research entities capable of administering federally funded biomedical research projects. Applications are expected to be submitted through standard federal grant submission systems following the release of the official opportunity package. The notice references the electronic Biomedical Research Application Portal, or eBRAP, which commonly serves as the pre-application and administrative management system for Congressionally Directed Medical Research Programs opportunities. The opportunity follows a projected timeline beginning with the forecast release on May 5, 2026 and an estimated official posting date of May 20, 2026. The estimated application due date is September 12, 2026. Awards are expected to be issued on or around September 30, 2027, with an estimated project start date of the same day. The funding opportunity appears to be part of an annually recurring Department of Defense research program cycle, suggesting future opportunities may follow similar schedules in subsequent fiscal years. Applicants seeking additional information may consult the Prostate Cancer Research Program pre-announcement page or contact the eBRAP Help Desk. The listed support contact includes the email address help@eBRAP.org and telephone number 301-682-5507 for applicant assistance related to electronic systems and submission processes.

Ensure the proposed research directly addresses one of the FY26 PCRP Overarching Challenges and clearly demonstrates how mentorship and the researcher development plan will support the applicant's transition toward independent prostate cancer research leadership.